VOR Vor Biopharma Inc.

Fundamentals / CIK 0001817229 / USD

Vor Biopharma Inc. reported $496.3M in total assets and net income of $1.35B through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VOR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$650.7MFY 2020 Net Income: -$43.34M2020FY 2021 Net Income: -$68.90M2021FY 2022 Net Income: -$92.09M2022FY 2023 Net Income: -$117.9M2023FY 2024 Net Income: -$116.9M2024FY 2025 Net Income: -$696.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $321.5M $93.31M $94.31M $64.55M $47.53M $31.62M
Total Operating Expenses $371.6M $121.2M $126.0M $93.42M $69.02M $43.37M
Operating Income -$371.6M -$121.2M -$126.0M -$93.42M -$69.02M -$43.37M
EBITDA -$368.8M -$117.7M -$122.5M -$90.89M -$67.58M -$42.76M
Interest Income $5.87M $4.27M $8.17M $1.32M $119K $29K
Net Income -$696.0M -$116.9M -$117.9M -$92.09M -$68.90M -$43.34M
Basic EPS -$70.50 -$34.03 -$35.00 -$46.60 -$42.00 -$4,611.40
Diluted EPS -$70.50 -$34.03 -$35.00 -$46.60 -$42.00 -$4,611.40
Basic Shares Outstanding 9.9M 3.4M 3.4M 2.0M 1.7M 10.7K
Diluted Shares Outstanding 9.9M 3.4M 3.4M 2.0M 1.7M 10.7K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $34.53M $25.92M $17.59M $19.19M $14.14M $261.5M $26.70M $25.35M
Total Operating Expenses $58.44M $47.85M $35.16M $35.96M $28.11M $274.3M $33.29M $31.31M
Operating Income -$58.44M -$47.85M -$35.16M -$35.96M -$28.11M -$274.3M -$33.29M -$31.31M
EBITDA -$58.41M -$47.82M -$35.13M -$35.94M -$26.01M -$272.2M -$32.47M -$30.45M
Interest Income $4.61M $4.34M $3.94M $2.79M $1.73M $537K $805K $599K
Net Income -$86.73M -$62.81M -$219.6M $1.72B -$812.7M -$1.57B -$32.49M -$30.71M
Basic EPS -$1.45 -$1.16 -$5.11 -- -$121.63 -$251.24 -$5.21 --
Diluted EPS -$1.45 -$1.16 -$5.11 -- -$121.63 -$251.24 -$5.21 --
Basic Shares Outstanding 59.7M 54.3M 43.0M -- 6.7M 6.3M 6.2M --
Diluted Shares Outstanding 59.7M 54.3M 43.0M -- 6.7M 6.3M 6.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $396.5M $81.95M $31.36M $57.71M $119.8M $48.54M
Short-Term Investments $58.72M $9.98M $105.8M $172.5M $87.67M $0
Cash & Short-Term Investments $455.2M $91.90M $137.2M $230.2M $207.5M $48.54M
Other Current Assets $1.75M $380K $475K $2.34M $2.09M $100K
Total Current Assets $458.1M $96.51M $140.8M $236.9M $214.4M $49.11M
Property, Plant & Equipment, Net $533K $6.58M $10.05M $12.63M $6.85M $4.73M
Other Non-Current Assets $2.38M $2.38M $4.81M $2.92M $3.25M $3.40M
Total Non-Current Assets $6.02M $46.38M $57.32M $62.42M $28.19M $26.80M
Total Assets $464.1M $142.9M $198.1M $299.4M $242.6M $75.91M
Accounts Payable $5.13M $1.50M $815K $1.77M $1.54M $2.36M
Other Current Liabilities -- $0 $50K $186K $434K $723K
Total Current Liabilities $25.17M $18.61M $15.57M $13.12M $10.15M $10.21M
Total Non-Current Liabilities $603.3M $27.61M $31.83M $35.64M $16.17M $17.43M
Total Liabilities $628.4M $46.23M $47.40M $48.76M $26.33M $27.64M
Total Debt (incl. Leases) $3.00M $31.83M $35.66M $38.91M $18.01M $18.29M
Common Stock $18K $13K $7.0K $7.0K $4.0K $1.0K
Retained Earnings -$1.15B -$457.0M -$340.1M -$222.2M -$130.1M -$61.22M
Accumulated Other Comp. Income $41K $22K -$77K -$770K -- --
Total Stockholders' Equity -$164.3M $96.66M $150.7M $250.6M $216.3M -$59.06M
Total Equity -$164.3M $96.66M $150.7M $250.6M $216.3M -$59.06M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $78.98M $107.9M $169.9M $396.5M $160.5M $190.6M $50.05M $81.95M
Short-Term Investments $402.6M $358.3M $321.7M $58.72M $10.00M $9.99M $9.99M $9.98M
Cash & Short-Term Investments $481.6M $466.1M $491.5M $455.2M $170.5M $200.6M $60.00M $91.90M
Other Current Assets $4.00M $3.10M $2.86M $1.75M $1.28M $449K $297K $380K
Total Current Assets $490.5M $475.1M $500.8M $458.1M $172.5M $204.9M $64.85M $96.51M
Property, Plant & Equipment, Net $623K $648K $565K $533K $271K $0 $5.99M $6.58M
Other Non-Current Assets $2.39M $2.41M $2.41M $2.38M $269K $420K $2.37M $2.38M
Total Non-Current Assets $5.79M $5.95M $5.97M $6.02M $3.75M $444K $44.47M $46.38M
Total Assets $496.3M $481.1M $506.7M $464.1M $176.2M $205.4M $109.3M $142.9M
Accounts Payable $5.61M $4.00M $1.04M $5.13M $885K $669K $3.73M $1.50M
Other Current Liabilities -- -- -- -- -- -- $44K $0
Total Current Liabilities $36.34M $24.81M $16.08M $25.17M $18.84M $58.77M $16.73M $18.61M
Total Non-Current Liabilities $597.1M $656.4M $641.1M $603.3M $2.38B $1.65B $26.52M $27.61M
Total Liabilities $633.5M $681.2M $657.2M $628.4M $2.40B $1.71B $43.24M $46.23M
Total Debt (incl. Leases) $2.81M $2.88M $2.94M $3.00M $3.06M -- $30.78M $31.83M
Common Stock $20K $19K $19K $18K $15K $13K $13K $13K
Retained Earnings -$1.52B -$1.44B -$1.37B -$1.15B -$2.88B -$2.06B -$489.5M -$457.0M
Accumulated Other Comp. Income -$1.84M -$922K -$706K $41K $12K $14K $23K $22K
Total Stockholders' Equity -$137.2M -$200.2M -$150.4M -$164.3M -$2.23B -$1.51B $66.07M $96.66M
Total Equity -$137.2M -$200.2M -$150.4M -$164.3M -$2.23B -$1.51B $66.07M $96.66M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$696.0M -$116.9M -$117.9M -$92.09M -$68.90M -$43.34M
Depreciation & Amortization $2.89M $3.53M $3.49M $2.52M $1.43M $605K
Stock-Based Compensation $18.91M $9.85M $13.36M $10.70M $4.32M $1.34M
Operating Cash Flow -$142.7M -$99.66M -$100.3M -$85.14M -$69.14M -$36.29M
Capital Expenditure -$941K -$229K -$1.07M -$8.46M -$3.89M -$4.16M
Free Cash Flow -$143.7M -$99.89M -$101.4M -$93.61M -$73.04M -$40.45M
Purchases of Investments -$53.66M -$9.91M -$74.92M -$123.2M -$87.76M --
Investing Cash Flow -$48.80M $96.86M $71.01M -$94.09M -$91.65M -$4.16M
Common Stock Issued $70.11M $275K $4.58M $4.45M -- --
Dividends Paid $0 $0 $0 $0 $0 $0
Financing Cash Flow $503.8M $53.39M $2.94M $117.1M $232.9M $82.53M
Net Change in Cash $312.3M $50.59M -$26.35M -$62.09M $72.12M $42.07M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$86.73M -$62.81M -$219.6M $1.72B -$812.7M -$1.57B -$32.49M -$30.71M
Depreciation & Amortization $39K $36K $28K $23K $2.10M $2.10M $825K $865K
Stock-Based Compensation $9.94M $9.40M $8.87M $7.11M $8.03M $1.84M $1.93M $1.71M
Operating Cash Flow -$32.75M -$25.38M -$38.25M -$22.80M -$53.66M -$35.18M -$31.07M -$24.06M
Capital Expenditure -$25K -$120K -$48K -$314K -$244K -$152K -$231K -$72K
Free Cash Flow -$32.77M -$25.50M -$38.29M -$23.11M -$53.91M -$35.34M -$31.30M -$24.14M
Purchases of Investments -$117.2M -$79.00M -$276.5M -$53.66M $0 $0 $0 $0
Investing Cash Flow -$44.78M -$36.53M -$263.2M -$48.97M -$244K $646K -$230K -$72K
Common Stock Issued -- -- -- $49.85M $20.26M $0 $0 -$22K
Financing Cash Flow $48.65M -$106K $74.87M $307.8M $21.55M $175.1M -$606K $53.29M
Net Change in Cash -$28.88M -$62.02M -$226.6M $236.0M -$32.36M $140.5M -$31.90M $29.15M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -120.9% -78.2% -36.7% -31.9% --
Return on Assets (ROA) -150.0% -81.8% -59.5% -30.8% -28.4% -57.1%
Current Ratio 18.20x 5.19x 9.04x 18.06x 21.12x 4.81x
Quick Ratio 18.08x 4.94x 8.81x 17.55x 20.43x 4.76x
Debt to Equity -- 0.33x 0.24x 0.16x 0.08x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -- -- -- -179.5% -120.9%
Return on Assets (ROA) 272.8% 130.5% -174.3% -150.0% -1389.9% -810.4% -108.5% -81.8%
Current Ratio 13.50x 19.15x 31.15x 18.20x 9.16x 3.49x 3.88x 5.19x
Quick Ratio 13.25x 18.78x 30.57x 18.08x 9.05x 3.41x 3.59x 4.94x
Debt to Equity -- -- -- -- -- -- 0.47x 0.33x
Source: SEC EDGAR CompanyFacts (CIK 0001817229) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:30 UTC · Open in terminal